Celltrion
068270.KS
#902
Rank
NZ$46.29 B
Marketcap
NZ$201.88
Share price
0.06%
Change (1 day)
-7.12%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): NZ$3.22

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$3.24. an increase over its 2024 EPS that were of NZ$2.11.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025NZ$5.55163.66%
2024NZ$2.11-53.73%
2023NZ$4.55-2.08%
2022NZ$4.65-11.72%
2021NZ$5.272.03%
2020NZ$5.1682.8%
2019NZ$2.8218.31%
2018NZ$2.39-36.33%
2017NZ$3.75161.25%
2016NZ$1.432.86%
2015NZ$1.4017.84%
2014NZ$1.185.87%
2013NZ$1.12-70.85%
2012NZ$3.84134.09%
2011NZ$1.6443.59%
2010NZ$1.1474.49%
2009NZ$0.65317.8%
2008NZ$0.16-71.7%
2007NZ$0.55